Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 16, 2026

NVIDIA Vera Rubin Opens Agentic AI Frontier

View original at finance.yahoo.com
NVIDIA Vera Rubin Opens Agentic AI Frontier NVIDIA Seven New Chips in Full Production to Scale the World’s Largest AI Factories With Configurable AI Infrastructure Optimized for Every Phase of AI, From Pretraining, Post-Training and Test-Time Scaling to Agentic Inference NVIDIA Vera RubinThe NVIDIA Vera Rubin platform…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Groq 3 LPX and Vera Rubin deliver up to 35x higher inference throughput per megawatt and up to 10x more revenue opportunity for trillion-parameter models

    60% confidence
  • Vera CPU delivers results twice as efficiently and 50% faster than traditional CPUs for agentic AI and reinforcement learning

    60% confidence
  • By delivering a new storage tier purpose-built for AI agents memory, STX is ideally positioned to ensure that our models can maintain coherence and speed when reasoning across massive datasets

    60% confidence
  • Vera Rubin NVL72 trains large mixture-of-experts models with one-fourth the number of GPUs compared with the NVIDIA Blackwell platform

    60% confidence
  • Enterprises and developers are using Claude for increasingly complex reasoning, agentic workflows and mission-critical decisions that demand infrastructure that can keep pace

    60% confidence
  • DOCA Memos enables dedicated KV cache storage processing to boost inference throughput by up to 5x while significantly improving power efficiency

    60% confidence
  • The agentic AI inflection point has arrived with Vera Rubin kicking off the greatest infrastructure buildout in history

    60% confidence
  • The NVIDIA BlueField-4 STX rack-scale context memory storage system will enable a critical performance boost needed to exponentially scale our agentic AI efforts

    60% confidence
  • NVIDIA infrastructure is the foundation that lets us keep pushing the frontier of AI

    60% confidence
  • Vera Rubin is a generational leap — seven breakthrough chips, five racks, one giant supercomputer — built to power every phase of AI

    60% confidence
  • DSX Flex software unlocks 100 gigawatts of stranded grid power by enabling AI factories to be grid-flexible assets

    60% confidence
  • NVIDIA's Vera Rubin platform gives us the compute, networking and system design to keep delivering while advancing the safety and reliability our customers depend on

    60% confidence
  • Spectrum-X Ethernet Photonics with co-packaged optics achieves up to 5x greater optical power efficiency and 10x higher resiliency compared with traditional pluggable transceivers

    60% confidence
  • With NVIDIA Vera Rubin, we'll run more powerful models and agents at massive scale and deliver faster, more reliable systems to hundreds of millions of people

    60% confidence
  • DSX Max-Q enables deployment of 30% more AI infrastructure within a fixed-power data center through dynamic power provisioning

    60% confidence
  • Vera Rubin NVL72 achieves up to 10x higher inference throughput per watt at one-tenth the cost per token compared to previous generation

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com